Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pigment Solution Program (PSP) as Adjuvant Therapy in Melasma
NCT06174545Recruiting
- Start
- Sep 2023
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Randomised, single-blind trial in melasma (2 arms). Primary endpoints: modified Melasma Severity Index at 84 days, Investigator Global Assessment at 84 days and 6 more. Started Sep 2023; status: recruiting.
02
Conditions
melasma
Beyond the preview
Go deeper on NCT06174545.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06174545.